Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adverum Biotechnologies, Inc. - Common Stock (NQ:ADVM)

4.330 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.330
Bid (Size) 4.220 (3,000)
Ask (Size) 4.440 (400)
Prev. Close 4.330
Today's Range 4.330 - 4.330
52wk Range 1.780 - 8.180
Shares Outstanding 98,125,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-9.8%
-9.8%
1 Month
+4.1%
+4.1%
3 Month
+75.3%
+75.3%
6 Month
+95.5%
+95.5%
1 Year
-44.2%
-44.2%

More News

Read More
Eli Lilly To Acquire Adverum Biotechnologies
Via Stocktwits
Halper Sadeh LLC Encourages ADVM, MOFG, HSII Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Via Benzinga
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
Top movers in Wednesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q2 2024
Via InvestorPlace
Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
Via Benzinga

Frequently Asked Questions

Is Adverum Biotechnologies, Inc. - Common Stock publicly traded?
Yes, Adverum Biotechnologies, Inc. - Common Stock is publicly traded.
What exchange does Adverum Biotechnologies, Inc. - Common Stock trade on?
Adverum Biotechnologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adverum Biotechnologies, Inc. - Common Stock?
The ticker symbol for Adverum Biotechnologies, Inc. - Common Stock is ADVM on the Nasdaq Stock Market
What is the current price of Adverum Biotechnologies, Inc. - Common Stock?
The current price of Adverum Biotechnologies, Inc. - Common Stock is 4.330
When was Adverum Biotechnologies, Inc. - Common Stock last traded?
The last trade of Adverum Biotechnologies, Inc. - Common Stock was at 11/11/25 04:00 PM ET
What is the market capitalization of Adverum Biotechnologies, Inc. - Common Stock?
The market capitalization of Adverum Biotechnologies, Inc. - Common Stock is 424.88M
How many shares of Adverum Biotechnologies, Inc. - Common Stock are outstanding?
Adverum Biotechnologies, Inc. - Common Stock has 425M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.